Anthem Biosciences IPO oversubscribed, set to list with 20-25% gain, raising ₹1,016 crore from anchor investors.

The much-awaited IPO allotment for Anthem Biosciences is now live. Investors who subscribed to the IPO between July 14 and ...

Indian drugmaker Anthem Biosciences' ANTH.NS $395 million IPO was fully subscribed on the second day of bidding on Tuesday, ...

Investors who bid for the issue can check the share allotment status on the websites of BSE, NSE and KFin Technologies by ...

The IPO, which opened for subscription on 14 July and closed on 16 July, witnessed strong investor interest, particularly ...

According to market observers, shares of the company are available at a premium of ₹156 in the grey market today ...

Anthem Biosciences Ltd.'s ₹3,395-crore initial public offering (IPO) in 2025 was oversubscribed by 63.86 times due to strong ...

Anthem Biosciences Ltd is expected to finalise its IPO share allotment status on Thursday, July 17. The ₹3,395-crore initial ...

The Anthem Biosciences IPO bidding window was open from July 14 to July 16, 2025. The share allotment is expected to be ...

The IPO of Anthem Biosciences fetched more than 37.94 applications as the issue fetched bids worth Rs 1.60 lakh crore for its ...

Anthem Biosciences' IPO ended on 16 July, with the issue booked over 60 times. Strong demand from qualified institutional ...

Since this IPO was fully an OFS, the contract research, development and manufacturing company will not receive any funds, ...